Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 1941841

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1941841

Brachytherapy Market Size, Share & Trends Analysis By Dosage Type (HDR, LDR), By Application (Prostate, Gynecological, Breast), By Product Seeds, Applicators & Afterloaders, Electronic Brachytherapy, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Brachytherapy Market Summary

The global brachytherapy market size was estimated at USD 1,112.97 million in 2025 and is projected to reach USD 1,967.19 million by 2033, growing at a CAGR of 7.4% from 2026 to 2033. The increasing prevalence of cancer, technological advancements, and a significant rise in the adoption of brachytherapy are expected to drive market growth during the forecast period.

According to the American Cancer Society, in the U.S., there were 618,000 cancer deaths and an estimated more than 2 million new cancer cases in 2025, and this rising global cancer burden continues to drive demand for effective localized treatment options such as brachytherapy. Radiation therapy, including brachytherapy, is used for prophylactic, palliative, or curative treatment and can be administered as monotherapy or as an adjunct to surgery, immunotherapy, and chemotherapy, increasing its clinical adoption among physicians. In 2024, advancements in imaging and treatment planning systems further enhanced the precision of brachytherapy dose delivery, reducing collateral damage to healthy tissues and improving clinical outcomes, which reinforced its role in comprehensive oncological care.

Ongoing research in 2025 is integrating artificial intelligence and automated treatment planning into high-dose-rate (HDR) brachytherapy protocols to improve consistency and efficiency of clinical workflows, addressing variability in manual planning practices. Despite technological progress, access challenges persist, particularly in low- and middle-income countries, where limited infrastructure and workforce shortages continue to restrict uptake; global radiotherapy resource assessments, such as the IAEA's Directory of Radiotherapy Centres, highlight the uneven distribution of brachytherapy units, which contributes to significant treatment gaps in these regions. For instance, in 2025, the American Radium Research Organization and ASTRO conducted a dedicated Brachytherapy Workshop during the ASTRO Annual Meeting, offering structured didactic sessions alongside hands-on training to strengthen practical brachytherapy competencies among residents and early-career physicians, thereby addressing gaps in procedural expertise.

More broadly, initiatives undertaken in 2025 emphasized workforce training and capacity building through targeted educational programs and professional development events aimed at improving access to high-quality brachytherapy services, particularly in underserved regions. Collectively, these clinical training advancements and capacity-building efforts are key factors shaping the evolving market landscape and supporting wider adoption of this targeted radiation therapy modality.

Global Brachytherapy Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global brachytherapy market report based on product, dosage type, application, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Seeds
  • Applicators & Afterloaders
  • Electronic Brachytherapy
  • Dosage type Outlook (Revenue, USD Million, 2021 - 2033)
  • High-Dose Rate (HDR)
  • Low-Dose Rate (LDR)
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Prostate
  • Gynecological Cancer
  • Breast
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-1-68038-618-9

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Dosage type
    • 1.2.3. Application
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Brachytherapy Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis

Chapter 4. Brachytherapy Market: Product Business Analysis

  • 4.1. Product Market Share, 2025 & 2033
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Seeds
    • 4.4.1. Seeds Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Applicators & Afterloaders
    • 4.5.1. Applicators & Afterloaders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Electronic Brachytherapy
    • 4.6.1. Electronic Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Brachytherapy Market: Dosage Type Business Analysis

  • 5.1. Dosage type Market Share, 2025 & 2033
  • 5.2. Dosage type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Dosage type, 2021 to 2033 (USD Million)
  • 5.4. High-Dose Rate (HDR)
    • 5.4.1. High-Dose Rate (HDR) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Low-Dose Rate (LDR)
    • 5.5.1. Low-Dose Rate (LDR) Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Brachytherapy Market: Application Business Analysis

  • 6.1. Application Market Share, 2025 & 2033
  • 6.2. Application Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Prostate
    • 6.4.1. Prostate Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Gynecological Cancer
    • 6.5.1. Gynecological Cancer Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Breast
    • 6.6.1. Breast Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Brachytherapy Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America Brachytherapy Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Type Disease Prevalence
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Framework
      • 7.4.2.5. U.S. Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Type Disease Prevalence
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Framework
      • 7.4.3.5. Canada Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Type Disease Prevalence
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Framework
      • 7.4.4.5. Mexico Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Type Disease Prevalence
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Framework
      • 7.5.2.5. UK Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Type Disease Prevalence
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Framework
      • 7.5.3.5. Germany Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Type Disease Prevalence
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement Framework
      • 7.5.4.5. France Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Type Disease Prevalence
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Reimbursement Framework
      • 7.5.5.5. Italy Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Type Disease Prevalence
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Reimbursement Framework
      • 7.5.6.5. Spain Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Type Disease Prevalence
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement Framework
      • 7.5.7.5. Denmark Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Type Disease Prevalence
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement Framework
      • 7.5.8.5. Sweden Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Type Disease Prevalence
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement Framework
      • 7.5.9.5. Norway Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Type Disease Prevalence
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Framework
      • 7.6.2.5. Japan Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Type Disease Prevalence
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Framework
      • 7.6.3.5. China Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Type Disease Prevalence
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Framework
      • 7.6.4.5. India Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Type Disease Prevalence
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Framework
      • 7.6.5.5. Australia Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Type Disease Prevalence
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement Framework
      • 7.6.6.5. South Korea Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Type Disease Prevalence
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement Framework
      • 7.6.7.5. Thailand Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Type Disease Prevalence
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement Framework
      • 7.7.2.5. Brazil Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Type Disease Prevalence
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement Framework
      • 7.7.3.5. Argentina Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Type Disease Prevalence
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement Framework
      • 7.8.2.5. South Africa Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Type Disease Prevalence
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement Framework
      • 7.8.3.5. Saudi Arabia Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Type Disease Prevalence
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement Framework
      • 7.8.4.5. UAE Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Type Disease Prevalence
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement Framework
      • 7.8.5.5. Kuwait Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Elekta AB
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Varian Medical Systems
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Eckert & Ziegler BEBIG
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. IsoRay
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Theragenics Corporation
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Best Medical International
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. CIVCO Medical Solutions
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Argon Medical Devices
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Panacea Medical Technologies
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Becton, Dickinson and Company
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
Show more
Product Code: GVR-1-68038-618-9

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global brachytherapy market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 5 Global brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 6 Global brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 7 North America brachytherapy market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 9 North America brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 10 North America brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 11 U.S. brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 12 U.S. brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 13 U.S. brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 14 Canada brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 15 Canada brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 16 Canada brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 17 Mexico brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 18 Mexico brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 19 Mexico brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 20 Europe brachytherapy market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 22 Europe brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 23 Europe brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 24 UK brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 25 UK brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 26 UK brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 27 Germany brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 28 Germany brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 29 Germany brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 30 France brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 31 France brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 32 France brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 33 Italy brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 34 Italy brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 35 Italy brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 36 Spain brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 37 Spain brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 38 Spain brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 39 Norway brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 40 Norway brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 41 Norway brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 42 Denmark brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 43 Denmark brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 44 Denmark brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 45 Sweden brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 46 Swede brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 47 Swede brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific brachytherapy market, by country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 52 Japan brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 53 Japan brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 54 Japan brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 55 China brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 56 China brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 57 China brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 58 India brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 59 India brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 60 India brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 61 Australia brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 62 Australia brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 63 Australia brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 64 South Korea brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 65 South Korea brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 66 South Korea brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 67 Thailand brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 68 Thailand brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 69 Thailand brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 70 Latin America brachytherapy market, by country, 2021 - 2033 (USD Million)
  • Table 71 Latin America brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 72 Latin America brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 73 Latin America brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 74 Brazil brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 75 Brazil brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 76 Brazil brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 77 Argentina brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 78 Argentina brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 79 Argentina brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa brachytherapy market, by country, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 84 South Africa brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 85 South Africa brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 86 South Africa brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 90 UAE brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 91 UAE brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 92 UAE brachytherapy market, by application, 2021 - 2033 (USD Million)
  • Table 93 Kuwait brachytherapy market, by product, 2021 - 2033 (USD Million)
  • Table 94 Kuwait brachytherapy market, by dosage type, 2021 - 2033 (USD Million)
  • Table 95 Kuwait brachytherapy market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Brachytherapy market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and disease outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Brachytherapy market dynamics
  • Fig. 12 Brachytherapy market: Porter's five forces analysis
  • Fig. 13 Brachytherapy market: PESTLE analysis
  • Fig. 14 Product market, 2021 - 2033 (USD Million)
  • Fig. 15 Seeds Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Applicators & Afterloaders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Electronic Brachytherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Dosage type market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 High-Dose Rate (HDR) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Low-Dose Rate (LDR) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Application market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Prostate market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Gynecological Cancer market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Breast market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Brachytherapy market revenue, by region
  • Fig. 27 Regional marketplace: Key takeaways
  • Fig. 28 North America brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. country dynamics
  • Fig. 30 U.S. brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Canada country dynamics
  • Fig. 32 Canada brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Mexico country dynamics
  • Fig. 34 Mexico brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Europe brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 UK country dynamics
  • Fig. 37 UK brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Germany country dynamics
  • Fig. 39 Germany brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 France country dynamics
  • Fig. 41 France brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Italy country dynamics
  • Fig. 43 Italy brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Spain country dynamics
  • Fig. 45 Spain brachytherapy market, 2021 - 2033 (USD Million)
  • Fig. 46 Norway country dynamics
  • Fig. 47 Norway brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Sweden country dynamics
  • Fig. 49 Sweden brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Denmark country dynamics
  • Fig. 51 Denmark brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Asia Pacific brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Japan country dynamics
  • Fig. 54 Japan brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 China country dynamics
  • Fig. 56 China brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 India country dynamics
  • Fig. 58 India brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Australia country dynamics
  • Fig. 60 Australia brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 South Korea country dynamics
  • Fig. 62 South Korea brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Thailand country dynamics
  • Fig. 64 Thailand brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Latin America brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Brazil country dynamics
  • Fig. 67 Brazil brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Argentina country dynamics
  • Fig. 69 Argentina brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 MEA brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 South Africa country dynamics
  • Fig. 72 South Africa brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Saudi Arabia country dynamics
  • Fig. 74 Saudi Arabia brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 UAE country dynamics
  • Fig. 76 UAE brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Kuwait country dynamics
  • Fig. 78 Kuwait brachytherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Company categorization
  • Fig. 80 Company market position analysis
  • Fig. 81 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!